Vaccine doses allocated to 9 African countries hardest hit by mpox surge
November 6, 2024
The Access and Allocation Mechanism (AAM) has allocated 899,000 mpox vaccine doses to nine African countries heavily affected by the current surge. The Democratic Republic of Congo will receive 85% of doses, as it reports 80% of Africa's confirmed cases with over 38,000 suspected cases and 1,000 deaths this year. The allocation, supported by international donors including Canada, EU nations, and the USA, targets countries based on readiness and epidemiological data. While vaccination has begun in DRC and Rwanda, this coordinated deployment represents a significant step in containing the outbreak, with more allocations expected by year-end.
The Access and Allocation Mechanism has launched a significant vaccine distribution effort to combat the mpox surge across Africa, marking a crucial step in regional disease control.
Key Elements:
1. Allocation Details:
- 899,000 vaccine doses distributed
- Nine recipient countries identified
- 85% allocated to DRC
- Based on readiness assessments
- Epidemiological data-driven decisions
2. Recipient Countries:
- Democratic Republic of Congo
- Central African Republic
- Côte d'Ivoire
- Kenya
- Liberia
- Nigeria
- Rwanda
- South Africa
- Uganda
3. Current Situation:
- 19 African countries reporting cases
- DRC: 38,000+ suspected cases
- Over 1,000 deaths reported
- Clade Ib strain causing concern
- Multiple newly affected countries
4. Implementation Strategy:
- Part of comprehensive response
- Focus on targeted vaccination
- Integration with testing and diagnosis
- Clinical care emphasis
- Community engagement
5. International Support:
- Multiple donor countries involved
- Partner organization coordination
- Resource mobilization ongoing
- Additional allocations planned
- Technical support provided
This initiative represents a coordinated international response to the mpox crisis, with further vaccine allocations expected before year-end.